Pulse Biosciences (NASDAQ:PLSE – Get Free Report) will release its earnings data after the market closes on Tuesday, May 7th. Persons that wish to register for the company’s earnings conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.21) earnings per share (EPS) for the quarter.
Pulse Biosciences Price Performance
Shares of NASDAQ:PLSE opened at $7.82 on Friday. The company’s 50 day simple moving average is $8.53 and its 200 day simple moving average is $8.32. Pulse Biosciences has a 1 year low of $3.78 and a 1 year high of $13.62.
About Pulse Biosciences
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Further Reading
- Five stocks we like better than Pulse Biosciences
- 3 Tickers Leading a Meme Stock Revival
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is Insider Trading? What You Can Learn from Insider Trading
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
